Mo1548 - Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study.

MLA

Fukudo, Shin, et al. “Mo1548 - Linaclotide Is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study.” Gastroenterology (00165085), vol. 152, Apr. 2017, p. S714. EBSCOhost, https://doi.org/10.1016/S0016-5085(17)32487-3.

APA

Fukudo, S., Miwa, H., Nakajima, A., Haruma, K., Kosako, M., Nakagawa, A., Akiho, H., Yamaguchi, Y., Johnston, J. M., Currie, M., & Kinoshita, Y. (2017). Mo1548 - Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study. Gastroenterology (00165085), 152, S714. https://doi.org/10.1016/S0016-5085(17)32487-3

Chicago

Fukudo, Shin, Hiroto Miwa, Atsushi Nakajima, Ken Haruma, Masanori Kosako, Ayako Nakagawa, Hiraku Akiho, et al. 2017. “Mo1548 - Linaclotide Is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study.” Gastroenterology (00165085) 152 (April): S714. doi:10.1016/S0016-5085(17)32487-3.